Extracellular vesicles (EVs) have emerged as promising natural nanocarriers for therapeutic delivery due to their biocompatibility and intrinsic cell-targeting capabilities. However, their clinical translation remains limited by low production yield and inefficient cargo loading. In this study, we present a novel acoustically driven platform that simultaneously enhances EV biogenesis and facilitates efficient nanoparticle encapsulation. Application of precisely tuned surface acoustic waves (SAWs) to cultured cells resulted in a 20-fold increase in EV production after 7 acoustic cycles, while maintaining cell viability above 80% over a 48-hour incubation period. Acoustic stimulation also enabled nanoparticle loading via transient membrane permeabilization, preserving EV integrity. Building on this platform, we are currently developing magnetic nanoparticle-loaded EVs for magnetic hyperthermia therapy, offering a contactless, scalable, and biocompatible strategy for multifunctional therapeutic delivery. Our findings highlight the potential of acoustic wave technology in EV engineering and its application in targeted cancer therapy and precision nanomedicine.